Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing
Background and Objectives Pigmentary disorders—such as hyperpigmentation and hypopigmentation, are devastating complications of erbium:yttrium‐aluminum‐garnet (Er:YAG) laser resurfacing. This study was undertaken to assess the clinical and histopathologic features of hyperpigmentation and hypopigmen...
Gespeichert in:
Veröffentlicht in: | Lasers in surgery and medicine 2005-01, Vol.36 (1), p.47-51 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 51 |
---|---|
container_issue | 1 |
container_start_page | 47 |
container_title | Lasers in surgery and medicine |
container_volume | 36 |
creator | Kim, Yong Ju Lee, Ho-Sup Son, Sang-Wook Kim, Soo-Nam Kye, Young-Chul |
description | Background and Objectives
Pigmentary disorders—such as hyperpigmentation and hypopigmentation, are devastating complications of erbium:yttrium‐aluminum‐garnet (Er:YAG) laser resurfacing. This study was undertaken to assess the clinical and histopathologic features of hyperpigmentation and hypopigmentation following Er:YAG laser resurfacing, especially in darker skin.
Study Design/Materials and Methods
One hundred and ninety patients (skin phototypes III and above), treated with Er:YAG lasers—short‐pulsed and modulated (variable‐pulsed and dual‐mode) Er:YAG lasers—for skin resurfacing were recruited. The clinical features of hyperpigmentation and hypopigmentation were evaluated retrospectively using medical charts and serial photographs. For histopathologic examinations, skin biopsies were performed in three patients at hyperpigmentation sites and in four patients at hypopigmentation sites.
Results
Hyperpigmentation was observed in 38.4% of the patients. Mean onset and duration were 3.5 and 7.2 weeks, and then it has faded away within 16 weeks in 93.2% of cases. Hypopigmentation was observed in 13.7% of the patients; its mean onset was 2 months after treatment, and it faded within 1 year in 85% of cases. The incidences and mean durations of these side effects were more intense and longer in patients treated with short‐pulsed, variable‐pulsed, and dual‐mode Er:YAG lasers, in increasing order. In terms of histopathologic examinations, melanin amounts in the epidermal basal layer were observed to vary.
Conclusions
Hyperpigmentation and hypopigmentation are frequent complications of Er:YAG laser resurfacing. Long pulse duration‐induced thermal damage seems to be the most important factor in terms of the induction of pigmentary disorders. Lasers Surg. Med. 36:47–51, 2005. © 2005 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/lsm.20120 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19429209</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19429209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3920-e72b70ba02b1813e18e1580e528f7e2759438c3b883d43f38a2e0fec923820e73</originalsourceid><addsrcrecordid>eNp1kE1PAjEQhhujEUQP_gGzJxMPC9N2l3a9EcKHCeoB1HhqusssVvYD2yXKv3cR1Hgwc5iZN8-8k7yEnFNoUwDWyVzeZkAZHJAmhajrRxToIWkCrWcJEWuQE-deAYAzEMekQcNul9XVJI-9QmcbZ5xXpt7LZoV2ZRY5FpWuTFl4uphv1fKvmFZovYG9fu6NvEy7enFLU3gW3dqmOjHF4pQcpTpzeLbvLfIwHMz6Y39yP7rp9yZ-wiMGPgoWC4g1sJhKypFKpKEEDJlMBTIRRgGXCY-l5POAp1xqhpBiEjEuGaDgLXK5813Z8m2NrlK5cQlmmS6wXDtFo4DVj6IavNqBiS2ds5iqlTW5thtFQW1DVHWI6ivEmr3Ym67jHOe_5D61GujsgHeT4eZ_JzWZ3n5b-rsL4yr8-LnQdqm6gotQPd2N1EyMh9MgGCrJPwGVIIpl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19429209</pqid></control><display><type>article</type><title>Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Kim, Yong Ju ; Lee, Ho-Sup ; Son, Sang-Wook ; Kim, Soo-Nam ; Kye, Young-Chul</creator><creatorcontrib>Kim, Yong Ju ; Lee, Ho-Sup ; Son, Sang-Wook ; Kim, Soo-Nam ; Kye, Young-Chul</creatorcontrib><description>Background and Objectives
Pigmentary disorders—such as hyperpigmentation and hypopigmentation, are devastating complications of erbium:yttrium‐aluminum‐garnet (Er:YAG) laser resurfacing. This study was undertaken to assess the clinical and histopathologic features of hyperpigmentation and hypopigmentation following Er:YAG laser resurfacing, especially in darker skin.
Study Design/Materials and Methods
One hundred and ninety patients (skin phototypes III and above), treated with Er:YAG lasers—short‐pulsed and modulated (variable‐pulsed and dual‐mode) Er:YAG lasers—for skin resurfacing were recruited. The clinical features of hyperpigmentation and hypopigmentation were evaluated retrospectively using medical charts and serial photographs. For histopathologic examinations, skin biopsies were performed in three patients at hyperpigmentation sites and in four patients at hypopigmentation sites.
Results
Hyperpigmentation was observed in 38.4% of the patients. Mean onset and duration were 3.5 and 7.2 weeks, and then it has faded away within 16 weeks in 93.2% of cases. Hypopigmentation was observed in 13.7% of the patients; its mean onset was 2 months after treatment, and it faded within 1 year in 85% of cases. The incidences and mean durations of these side effects were more intense and longer in patients treated with short‐pulsed, variable‐pulsed, and dual‐mode Er:YAG lasers, in increasing order. In terms of histopathologic examinations, melanin amounts in the epidermal basal layer were observed to vary.
Conclusions
Hyperpigmentation and hypopigmentation are frequent complications of Er:YAG laser resurfacing. Long pulse duration‐induced thermal damage seems to be the most important factor in terms of the induction of pigmentary disorders. Lasers Surg. Med. 36:47–51, 2005. © 2005 Wiley‐Liss, Inc.</description><identifier>ISSN: 0196-8092</identifier><identifier>EISSN: 1096-9101</identifier><identifier>DOI: 10.1002/lsm.20120</identifier><identifier>PMID: 15662626</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Cicatrix - radiotherapy ; Er:YAG laser resurfacing ; Female ; Follow-Up Studies ; Humans ; Hydroquinones - therapeutic use ; hyperpigmentation ; Hyperpigmentation - drug therapy ; Hyperpigmentation - etiology ; Hyperpigmentation - pathology ; hypopigmentation ; Hypopigmentation - etiology ; Hypopigmentation - pathology ; Lasers - adverse effects ; Male ; Middle Aged ; Radiation-Protective Agents - therapeutic use ; Remission, Spontaneous ; Retrospective Studies ; Time Factors</subject><ispartof>Lasers in surgery and medicine, 2005-01, Vol.36 (1), p.47-51</ispartof><rights>Copyright © 2005 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3920-e72b70ba02b1813e18e1580e528f7e2759438c3b883d43f38a2e0fec923820e73</citedby><cites>FETCH-LOGICAL-c3920-e72b70ba02b1813e18e1580e528f7e2759438c3b883d43f38a2e0fec923820e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Flsm.20120$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Flsm.20120$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15662626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Yong Ju</creatorcontrib><creatorcontrib>Lee, Ho-Sup</creatorcontrib><creatorcontrib>Son, Sang-Wook</creatorcontrib><creatorcontrib>Kim, Soo-Nam</creatorcontrib><creatorcontrib>Kye, Young-Chul</creatorcontrib><title>Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing</title><title>Lasers in surgery and medicine</title><addtitle>Lasers Surg. Med</addtitle><description>Background and Objectives
Pigmentary disorders—such as hyperpigmentation and hypopigmentation, are devastating complications of erbium:yttrium‐aluminum‐garnet (Er:YAG) laser resurfacing. This study was undertaken to assess the clinical and histopathologic features of hyperpigmentation and hypopigmentation following Er:YAG laser resurfacing, especially in darker skin.
Study Design/Materials and Methods
One hundred and ninety patients (skin phototypes III and above), treated with Er:YAG lasers—short‐pulsed and modulated (variable‐pulsed and dual‐mode) Er:YAG lasers—for skin resurfacing were recruited. The clinical features of hyperpigmentation and hypopigmentation were evaluated retrospectively using medical charts and serial photographs. For histopathologic examinations, skin biopsies were performed in three patients at hyperpigmentation sites and in four patients at hypopigmentation sites.
Results
Hyperpigmentation was observed in 38.4% of the patients. Mean onset and duration were 3.5 and 7.2 weeks, and then it has faded away within 16 weeks in 93.2% of cases. Hypopigmentation was observed in 13.7% of the patients; its mean onset was 2 months after treatment, and it faded within 1 year in 85% of cases. The incidences and mean durations of these side effects were more intense and longer in patients treated with short‐pulsed, variable‐pulsed, and dual‐mode Er:YAG lasers, in increasing order. In terms of histopathologic examinations, melanin amounts in the epidermal basal layer were observed to vary.
Conclusions
Hyperpigmentation and hypopigmentation are frequent complications of Er:YAG laser resurfacing. Long pulse duration‐induced thermal damage seems to be the most important factor in terms of the induction of pigmentary disorders. Lasers Surg. Med. 36:47–51, 2005. © 2005 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>Cicatrix - radiotherapy</subject><subject>Er:YAG laser resurfacing</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hydroquinones - therapeutic use</subject><subject>hyperpigmentation</subject><subject>Hyperpigmentation - drug therapy</subject><subject>Hyperpigmentation - etiology</subject><subject>Hyperpigmentation - pathology</subject><subject>hypopigmentation</subject><subject>Hypopigmentation - etiology</subject><subject>Hypopigmentation - pathology</subject><subject>Lasers - adverse effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Radiation-Protective Agents - therapeutic use</subject><subject>Remission, Spontaneous</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><issn>0196-8092</issn><issn>1096-9101</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1PAjEQhhujEUQP_gGzJxMPC9N2l3a9EcKHCeoB1HhqusssVvYD2yXKv3cR1Hgwc5iZN8-8k7yEnFNoUwDWyVzeZkAZHJAmhajrRxToIWkCrWcJEWuQE-deAYAzEMekQcNul9XVJI-9QmcbZ5xXpt7LZoV2ZRY5FpWuTFl4uphv1fKvmFZovYG9fu6NvEy7enFLU3gW3dqmOjHF4pQcpTpzeLbvLfIwHMz6Y39yP7rp9yZ-wiMGPgoWC4g1sJhKypFKpKEEDJlMBTIRRgGXCY-l5POAp1xqhpBiEjEuGaDgLXK5813Z8m2NrlK5cQlmmS6wXDtFo4DVj6IavNqBiS2ds5iqlTW5thtFQW1DVHWI6ivEmr3Ym67jHOe_5D61GujsgHeT4eZ_JzWZ3n5b-rsL4yr8-LnQdqm6gotQPd2N1EyMh9MgGCrJPwGVIIpl</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Kim, Yong Ju</creator><creator>Lee, Ho-Sup</creator><creator>Son, Sang-Wook</creator><creator>Kim, Soo-Nam</creator><creator>Kye, Young-Chul</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>200501</creationdate><title>Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing</title><author>Kim, Yong Ju ; Lee, Ho-Sup ; Son, Sang-Wook ; Kim, Soo-Nam ; Kye, Young-Chul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3920-e72b70ba02b1813e18e1580e528f7e2759438c3b883d43f38a2e0fec923820e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Cicatrix - radiotherapy</topic><topic>Er:YAG laser resurfacing</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hydroquinones - therapeutic use</topic><topic>hyperpigmentation</topic><topic>Hyperpigmentation - drug therapy</topic><topic>Hyperpigmentation - etiology</topic><topic>Hyperpigmentation - pathology</topic><topic>hypopigmentation</topic><topic>Hypopigmentation - etiology</topic><topic>Hypopigmentation - pathology</topic><topic>Lasers - adverse effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Radiation-Protective Agents - therapeutic use</topic><topic>Remission, Spontaneous</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Yong Ju</creatorcontrib><creatorcontrib>Lee, Ho-Sup</creatorcontrib><creatorcontrib>Son, Sang-Wook</creatorcontrib><creatorcontrib>Kim, Soo-Nam</creatorcontrib><creatorcontrib>Kye, Young-Chul</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Lasers in surgery and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Yong Ju</au><au>Lee, Ho-Sup</au><au>Son, Sang-Wook</au><au>Kim, Soo-Nam</au><au>Kye, Young-Chul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing</atitle><jtitle>Lasers in surgery and medicine</jtitle><addtitle>Lasers Surg. Med</addtitle><date>2005-01</date><risdate>2005</risdate><volume>36</volume><issue>1</issue><spage>47</spage><epage>51</epage><pages>47-51</pages><issn>0196-8092</issn><eissn>1096-9101</eissn><abstract>Background and Objectives
Pigmentary disorders—such as hyperpigmentation and hypopigmentation, are devastating complications of erbium:yttrium‐aluminum‐garnet (Er:YAG) laser resurfacing. This study was undertaken to assess the clinical and histopathologic features of hyperpigmentation and hypopigmentation following Er:YAG laser resurfacing, especially in darker skin.
Study Design/Materials and Methods
One hundred and ninety patients (skin phototypes III and above), treated with Er:YAG lasers—short‐pulsed and modulated (variable‐pulsed and dual‐mode) Er:YAG lasers—for skin resurfacing were recruited. The clinical features of hyperpigmentation and hypopigmentation were evaluated retrospectively using medical charts and serial photographs. For histopathologic examinations, skin biopsies were performed in three patients at hyperpigmentation sites and in four patients at hypopigmentation sites.
Results
Hyperpigmentation was observed in 38.4% of the patients. Mean onset and duration were 3.5 and 7.2 weeks, and then it has faded away within 16 weeks in 93.2% of cases. Hypopigmentation was observed in 13.7% of the patients; its mean onset was 2 months after treatment, and it faded within 1 year in 85% of cases. The incidences and mean durations of these side effects were more intense and longer in patients treated with short‐pulsed, variable‐pulsed, and dual‐mode Er:YAG lasers, in increasing order. In terms of histopathologic examinations, melanin amounts in the epidermal basal layer were observed to vary.
Conclusions
Hyperpigmentation and hypopigmentation are frequent complications of Er:YAG laser resurfacing. Long pulse duration‐induced thermal damage seems to be the most important factor in terms of the induction of pigmentary disorders. Lasers Surg. Med. 36:47–51, 2005. © 2005 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15662626</pmid><doi>10.1002/lsm.20120</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0196-8092 |
ispartof | Lasers in surgery and medicine, 2005-01, Vol.36 (1), p.47-51 |
issn | 0196-8092 1096-9101 |
language | eng |
recordid | cdi_proquest_miscellaneous_19429209 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Adult Cicatrix - radiotherapy Er:YAG laser resurfacing Female Follow-Up Studies Humans Hydroquinones - therapeutic use hyperpigmentation Hyperpigmentation - drug therapy Hyperpigmentation - etiology Hyperpigmentation - pathology hypopigmentation Hypopigmentation - etiology Hypopigmentation - pathology Lasers - adverse effects Male Middle Aged Radiation-Protective Agents - therapeutic use Remission, Spontaneous Retrospective Studies Time Factors |
title | Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A01%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20hyperpigmentation%20and%20hypopigmentation%20after%20Er:YAG%20laser%20skin%20resurfacing&rft.jtitle=Lasers%20in%20surgery%20and%20medicine&rft.au=Kim,%20Yong%20Ju&rft.date=2005-01&rft.volume=36&rft.issue=1&rft.spage=47&rft.epage=51&rft.pages=47-51&rft.issn=0196-8092&rft.eissn=1096-9101&rft_id=info:doi/10.1002/lsm.20120&rft_dat=%3Cproquest_cross%3E19429209%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19429209&rft_id=info:pmid/15662626&rfr_iscdi=true |